Sha et al. [11] found that ORAI2 promotes gastric cancer cell migration and tumor metastasis through MAPK-dependent focal adhesion disassembly and PI3K/Akt signaling, which suggests the possibility of developing potential therapies for GC by targeting the ORAI2 signaling pathway. The gene discussed is ORAI2; the disease is neoplasm.